United States HR 9679: To increase the number of manufacturers registered under the Controlled Substances Act to manufacture cannabis for legitimate research purposes, to authorize health care providers of the Department of Veterans Affairs to provide recommendations to veterans regarding participation in federally approved cannabis clinical trials, and for other purposes.

Status: Introduced in House (as of 2022-12-22)

State: United States · Session: 117 · Bill: HR 9679

Sponsors: Matt Gaetz

View United States HR 9679 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.